Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, P. R. China.
Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, P. R. China; MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, P. R. China.
J Hepatol. 2021 Mar;74(3):627-637. doi: 10.1016/j.jhep.2020.10.021. Epub 2020 Oct 31.
BACKGROUND & AIMS: Macrophages (Mϕ) represent a major component of tumor tissues and play an important role in both tumor progression and therapeutic response. Although tumor Mϕ are generally considered to be derived from circulating monocytes, emerging evidence indicates that tissue Mϕ pools can be maintained by self-renewal. We aimed to elucidate the contribution, phenotype, and regulatory mechanisms of proliferating Mϕ in human hepatocellular carcinoma (HCC).
Flow cytometry analyses were performed to examine the presence and phenotype of proliferating Mϕ in fresh HCC tissues. Dual immunofluorescence staining was applied to analyze the prognostic value of proliferating Mϕ. The underlying regulatory mechanisms were examined using human monocyte-derived Mϕ.
Tumor-infiltrating Mϕ exhibited a significantly higher proliferative capacity than Mϕ in non-tumor tissues. A higher level of Mϕ proliferation was positively correlated with Mϕ density in the tumor and a poor prognosis in patients with HCC. Proliferating Mϕ were less differentiated (with increased CD206 expression) and were induced by the tumor cell-derived soluble small molecule, adenosine, but not proteins, lipids, or large peptides. Mechanistic studies demonstrated that autocrine granulocyte-macrophage colony-stimulating factor (GM-CSF) released by tumor-stimulated Mϕ could enhance A2A receptor expression on Mϕ and function synergistically with adenosine to elicit Mϕ proliferation in HCC.
Local Mϕ proliferation is an important mechanism for Mϕ accumulation in HCC tissues. Tumor-derived adenosine functions synergistically with autocrine GM-CSF released from activated Mϕ, which promotes Mϕ proliferation. Thus, selective modulation of Mϕ accumulation at the source may provide a novel strategy for cancer therapy.
Tumor-associated macrophages (TAMs) have been reported to play an essential role in both tumor progression and therapeutic response. A fundamental understanding of the mechanisms that regulate macrophage accumulation in tumors will undoubtedly lead to the development of strategies to target macrophages with high specificity and efficiency. The current study unveils a novel mechanism by which local proliferation is linked to macrophage accumulation in the tumor milieu, identifying potential targets for future immune-based anticancer therapies.
巨噬细胞(Mϕ)是肿瘤组织的主要组成部分,在肿瘤进展和治疗反应中发挥着重要作用。尽管肿瘤 Mϕ 通常被认为来源于循环单核细胞,但新出现的证据表明,组织 Mϕ 池可以通过自我更新来维持。我们旨在阐明增殖 Mϕ 在人肝细胞癌(HCC)中的贡献、表型和调控机制。
通过流式细胞术分析检查新鲜 HCC 组织中增殖 Mϕ 的存在和表型。应用双重免疫荧光染色分析增殖 Mϕ 的预后价值。使用人单核细胞衍生的 Mϕ 研究潜在的调控机制。
肿瘤浸润 Mϕ 的增殖能力明显高于非肿瘤组织中的 Mϕ。Mϕ 增殖水平越高,肿瘤中 Mϕ 密度越高,HCC 患者预后越差。增殖 Mϕ分化程度较低(CD206 表达增加),由肿瘤细胞衍生的可溶性小分子腺苷诱导,但不受蛋白质、脂质或大肽的影响。机制研究表明,肿瘤刺激的 Mϕ 释放的自分泌粒细胞-巨噬细胞集落刺激因子(GM-CSF)可增强 Mϕ 上 A2A 受体的表达,并与腺苷协同作用,在 HCC 中引发 Mϕ 增殖。
局部 Mϕ 增殖是 HCC 组织中 Mϕ 聚集的重要机制。肿瘤衍生的腺苷与激活的 Mϕ 释放的自分泌 GM-CSF 协同作用,促进 Mϕ 增殖。因此,选择性调节来源处的 Mϕ 聚集可能为癌症治疗提供新策略。
肿瘤相关巨噬细胞(TAMs)已被报道在肿瘤进展和治疗反应中发挥着重要作用。深入了解调节肿瘤中巨噬细胞积累的机制无疑将导致开发出具有高特异性和高效率的靶向巨噬细胞的策略。本研究揭示了一种新的机制,即局部增殖与肿瘤微环境中巨噬细胞的积累有关,为未来基于免疫的抗癌治疗确定了潜在的靶点。